TY - JOUR
T1 - Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer
T2 - sentinel node concept
AU - Takeuchi, Masashi
AU - Takeuchi, Hiroya
AU - Kawakubo, Hirofumi
AU - Shimada, Ayako
AU - Nakahara, Tadaki
AU - Mayanagi, Shuhei
AU - Niihara, Masahiro
AU - Fukuda, Kazumasa
AU - Nakamura, Rieko
AU - Suda, Koichi
AU - Wada, Norihito
AU - Kitagawa, Yuko
N1 - Publisher Copyright:
© 2018, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
PY - 2019/1/22
Y1 - 2019/1/22
N2 - Background: Sentinel node (SN) concept is being applied to early gastric cancer. However, when SNs are positive for metastasis, it is unclear how often LNs in other LN basins show metastasis. We aimed to investigate LN metastasis possibility in LN basins without SNs (non-SN basins). We determined risk factors for metastasis in non-SN basins and identified a prediction model for non-SN basin metastasis using classification and regression tree (CART) analysis. Methods: We enrolled 550 patients who were diagnosed with cT1N0M0 or cT2N0M0 gastric cancer with a single lesion and underwent SN mapping. We adopted a dual-tracer method using a radioactive colloid and blue dye to detect SNs. Results: Of all, 45 (8.2%) patients had SN metastasis; we divided them into two groups: LN metastasis positive and LN metastasis negative in non-SN basins. Univariate analysis showed that the groups differed significantly regarding lymphatic invasion (p = 0.007), number of identified SNs (p = 0.032), and macrometastasis in SN basins (p = 0.005). The CART decision tree for predicting LN metastasis in non-SN basins had area under the curve value of 0.86. Moreover, there were significantly differences in cancer-specific survival (CSS) between the two groups (p = 0.028). Conclusions: Macrometastasis in SN basins, lymphatic invasion, and number of identified SNs ≥ 5 are risk factors for LN metastasis in non-SN basins among gastric cancer patients. We identified a prediction model with CART analysis; patients with macrometastasis in SN basins and lymphatic invasion were considered to be at the highest risk for LN metastasis.
AB - Background: Sentinel node (SN) concept is being applied to early gastric cancer. However, when SNs are positive for metastasis, it is unclear how often LNs in other LN basins show metastasis. We aimed to investigate LN metastasis possibility in LN basins without SNs (non-SN basins). We determined risk factors for metastasis in non-SN basins and identified a prediction model for non-SN basin metastasis using classification and regression tree (CART) analysis. Methods: We enrolled 550 patients who were diagnosed with cT1N0M0 or cT2N0M0 gastric cancer with a single lesion and underwent SN mapping. We adopted a dual-tracer method using a radioactive colloid and blue dye to detect SNs. Results: Of all, 45 (8.2%) patients had SN metastasis; we divided them into two groups: LN metastasis positive and LN metastasis negative in non-SN basins. Univariate analysis showed that the groups differed significantly regarding lymphatic invasion (p = 0.007), number of identified SNs (p = 0.032), and macrometastasis in SN basins (p = 0.005). The CART decision tree for predicting LN metastasis in non-SN basins had area under the curve value of 0.86. Moreover, there were significantly differences in cancer-specific survival (CSS) between the two groups (p = 0.028). Conclusions: Macrometastasis in SN basins, lymphatic invasion, and number of identified SNs ≥ 5 are risk factors for LN metastasis in non-SN basins among gastric cancer patients. We identified a prediction model with CART analysis; patients with macrometastasis in SN basins and lymphatic invasion were considered to be at the highest risk for LN metastasis.
UR - http://www.scopus.com/inward/record.url?scp=85047330204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047330204&partnerID=8YFLogxK
U2 - 10.1007/s10120-018-0840-z
DO - 10.1007/s10120-018-0840-z
M3 - Article
C2 - 29799060
AN - SCOPUS:85047330204
SN - 1436-3291
VL - 22
SP - 223
EP - 230
JO - Gastric Cancer
JF - Gastric Cancer
IS - 1
ER -